Skip to main content
. 2020 Jan 3;51:102547. doi: 10.1016/j.ebiom.2019.11.008

Fig. 2.

Fig. 2

Expression of SNRNP200, SRRM1 and SRSF3 in a highly aggressive cohort of prostate cancer (PCa) samples. (a) SNRNP200, SRRM1 and SRSF3 expression levels in a battery of highly-aggressive PCa samples, with or without the presence of metastasis (n = 42). represent the mean ± SEM of mRNA expression levels. b-f) Correlation between SNRNP200, SRRM1 and SRSF3 expression levels and Gleason score (b), expression levels of AR-v7 (c), AR (d) MKI67 (e) and KLK3 (f). mRNA levels were determined by a microfluidic-based qPCR array and adjusted by normalization factor calculated from ACTB and GAPDH expression levels. Asterisk (* p < 0.05) indicates statistically significant differences between groups.